EUCTR2007-005373-58-IT进行中（未招募）不适用
EVALUATION OF DIAGNOSTIC ACCURACY OF 68GA-CITRATE PET/CT IN PATIENTS WITH INFLAMMATORY-INFECTIOUS DISEASES. - ND
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI0 个研究点开始时间: 2007年10月12日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1.Patients must be affected by: infected hip prosthesis, infected knee prosthesis, diabetic foot infection, spondilodiscitis, granulomatous pulmonary diseases, inflammatory bowel diseases, vasculitis, without antibiotic, anti-inflammatory and immunosoppressive therapy.
- •2.Age 18 years.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1.Age < 18 years
- •2.On-going antibiotic, anti-inflammatory and immunosoppressive therapy.
- •3.Pregnancy.
研究者
相似试验
进行中（未招募）
不适用
Comparison among 68-Ga-labeled octreotide analogues PET, TC and endoscopic ultrasonography in the study of duodeno-pancreatic neuroendocrine tumors.EUCTR2012-000994-22-ITAZIENDA OSPEDALIERA ARCISPEDALE S. MARIA NUOVA142
进行中（未招募）
1 期
Evaluation of diagnostic accuracy of [68Ga]Ga-PSMA-11 PET/CT in primary staging of Intermediate and High Risk Prostatic Cancer in men newly diagnosedMen with histo-pathological confirmation of PCa with intermediate or high-risk disease according to 2019 Prostate Cancer EAU Guidelines Risk Group StratificationMedDRA version: 21.1Level: LLTClassification code 10036927Term: Prostate neoplasiaSystem Organ Class: 100000004864EUCTR2019-004685-18-ITAZIENDA OSPEDALIERO-UNIVERSITARIA DI MODENA100
招募中
2 期
Evaluation of 68Ga-FAPI radiotracer in lung cancerung cancer.Malignant neoplasm of bronchus and lungIRCT20220817055732N1Shahid Beheshti University of Medical Sciences20
进行中（未招募）
不适用
Diagnostic procedure with 68Ga-labelled somatostatin analogues in tumours presumably expressing SSTR2 and/or 5 receptors, to be evaluated for treatment with the same analogues labelled with 90Y o 177Lu - NDValutation of expression of receptors SSTR2 and/or 5 in neoplastic patientsMedDRA version: 9.1Level: HLGTClassification code 10022893Term: Investigations, imaging and histopathology procedures NECEUCTR2008-000983-17-ITAZIENDA OSPEDALIERA ARCISPEDALE S. MARIA NUOVA
已完成
不适用
Comparison of the diagnostic value of Ga-67 scan and F-18 DG PET in sarcoidosis patientsNL-OMON34129nucleaire geneeskunde40